Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Azacitidine

Brands: Vidaza · Azacitidine

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1251
US makers18 labelers
Packages24
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.9K5.8K8.7K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.4K
Rx · 2026 Q1
9.6K
Units dispensed
-46%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Dr.Reddy's laboratories Limitedunknown4SUPPLYING
BluePoint Laboratoriesunknown3SUPPLYING
Meitheal Pharmaceuticals Inc.unknown2SUPPLYING
Fresenius Kabi USA, LLCunknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Sandoz Incunknown1SUPPLYING
MSN Laboratories Private Limitedunknown1SUPPLYING
Accord Healthcare Inc.unknown1SUPPLYING
Armas Pharmaceuticals Inc.unknown1SUPPLYING
Eugia US LLCunknown1SUPPLYING
Reliance Life Sciences Private Limitedunknown1SUPPLYING
Celgene Corporationunknown1SUPPLYING
Apotex Corp.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Somerset Therapeutics, LLCunknown1SUPPLYING

+ 3 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 22, 2022
    RECALLRecall (Class III): Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint L…

    Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification. — Recalling firm: Teva Pharmaceuticals USA Inc — Distributed in Ohio

  • Jan 19, 2022
    RECALLRecall (Class III): Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530…

    Failed stability specifications — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide

  • Jan 19, 2022
    RECALLRecall (Class III): Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 …

    Failed stability specifications — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide

  • Dec 22, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Teva Pharmaceuticals USA, Inc.)

    Azacitidine Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.

  • Dec 22, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Eugia US LLC)

    Azacitidine Injection — reported in shortage by Eugia US LLC. Therapeutic category: Oncology.

  • Dec 21, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Accord Healthcare Inc.)

    Azacitidine Injection — reported in shortage by Accord Healthcare Inc.. Therapeutic category: Oncology.

  • Dec 18, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Meitheal Pharmaceuticals, Inc.)

    Azacitidine Injection — reported in shortage by Meitheal Pharmaceuticals, Inc.. Therapeutic category: Oncology.

  • Dec 18, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Hikma Pharmaceuticals USA, Inc.)

    Azacitidine Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Oncology.

  • Dec 18, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Fresenius Kabi USA, LLC)

    Azacitidine Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.

  • Dec 18, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Bristol Myers Squibb Co.)

    Azacitidine Injection — reported in shortage by Bristol Myers Squibb Co.. Therapeutic category: Oncology.

  • Dec 18, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Dr. Reddy's Laboratories, Inc.)

    Azacitidine Injection — reported in shortage by Dr. Reddy's Laboratories, Inc.. Therapeutic category: Oncology.

  • Dec 18, 2020
    SHORTAGEDrug shortage: Azacitidine Injection (Armas Pharmaceuticals Inc)

    Azacitidine Injection — reported in shortage by Armas Pharmaceuticals Inc. Therapeutic category: Oncology.

  • Dec 8, 2020
    RECALLRecall (Class II): Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytoto…

    CGMP Deviations — Recalling firm: Shilpa Medicare Limited — Nationwide in the U.S.